Clinical Trial Update: Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers

View source ↗

Summary

A completed clinical trial explored subjective well-being in bipolar disorder patients treated with atypical antipsychotics as monotherapy or in combination wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Atypical antipsychotics (unspecified)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder | Status: COMPLETED